UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

A second space age spanning omics, platforms and medicine across orbits

Mason, Christopher E; Green, James; Adamopoulos, Konstantinos I; Afshin, Evan E; Baechle, Jordan J; Basner, Mathias; Bailey, Susan M; ... Beheshti, Afshin; + view all (2024) A second space age spanning omics, platforms and medicine across orbits. Nature , 632 pp. 995-1008. 10.1038/s41586-024-07586-8. Green open access

[thumbnail of s41586-024-07586-8_reference.pdf]
Preview
Text
s41586-024-07586-8_reference.pdf - Accepted Version

Download (3MB) | Preview

Abstract

The recent acceleration of commercial, private, and multi-national spaceflight has created an unprecedented level of activity in low Earth orbit (LEO), concomitant with the highest-ever number of crewed missions entering space and preparations for exploration-class (>1 year) missions. Such rapid advancement into space from many new companies, countries, and space-related entities has enabled a"Second Space Age." This new era is also poised to leverage, for the first time, modern tools and methods of molecular biology and precision medicine, thus enabling precision aerospace medicine for the crews. The applications of these biomedical technologies and algorithms are diverse, encompassing multi-omic, single-cell, and spatial biology tools to investigate human and microbial responses to spaceflight. Additionally, they extend to the development of new imaging techniques, real-time cognitive assessments, physiological monitoring, and personalized risk profiles tailored for astronauts. Furthermore, these technologies enable advancements in pharmacogenomics (PGx), as well as the identification of novel spaceflight biomarkers and the development of corresponding countermeasures. In this review, we highlight some of the recent biomedical research from the National Aeronautics and Space Administration (NASA), Japan Aerospace Exploration Agency (JAXA), European Space Agency (ESA), and other space agencies, and also detail the commercial spaceflight sector's (e.g. SpaceX, Blue Origin, Axiom, Sierra Space) entrance into aerospace medicine and space biology, the first aerospace medicine biobank, and the myriad upcoming missions that will utilize these tools to ensure a permanent human presence beyond LEO, venturing out to other planets and moons.

Type: Article
Title: A second space age spanning omics, platforms and medicine across orbits
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41586-024-07586-8
Publisher version: http://dx.doi.org/10.1038/s41586-024-07586-8
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Renal Medicine
URI: https://discovery.ucl.ac.uk/id/eprint/10193432
Downloads since deposit
1Download
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item